Key result
Aggressive sodium supplementation corrects refractory hyponatremia in a neonate with renal pseudohypoaldosteronism type I.
Case Report (n=1)
No
This case underscores the need to consider inherited renal tubulopathies in neonates with refractory hyponatraemia and highlights the pivotal role of genetic testing in precise diagnosis.
Consider renal PHA I in neonates with hyperbilirubinaemia and refractory hyponatraemia; leaves open phenotypic spectrum and requires dedicated studies.
Pseudohypoaldosteronism type I (PHA I) is a rare hereditary disorder of mineralocorticoid resistance, with the renal form predominantly caused by NR3C2 variants. We report a male neonate presenting with severe hyperbilirubinaemia who was subsequently diagnosed with renal PHA I. Born at 38⁺⁶ weeks, he was admitted on day 7 for jaundice. Laboratory evaluation revealed refractory hyponatraemia, markedly elevated plasma aldosterone and renin levels, and ineffective conventional electrolyte therapy. Whole-exome sequencing identified a de novo heterozygous nonsense variant, c.1954C>T (p.Arg652*), in NR3C2, confirming the diagnosis. Aggressive sodium supplementation corrected the electrolyte imbalance, and follow-up showed normal growth and stable serum sodium. This case underscores the need to consider inherited renal tubulopathies in neonates with refractory hyponatraemia and highlights the pivotal role of genetic testing in precise diagnosis.
No takes yet. Share an insight, caveat, or question.
Hj et al. (2026) conducted a case report in Neonatal renal pseudohypoaldosteronism type I (n=1). Sodium supplementation vs. Empirical sodium supplementation (3.4 mmol/kg/day) was evaluated on Serum sodium levels. Aggressive sodium supplementation corrected refractory hyponatraemia in a male neonate with renal pseudohypoaldosteronism type I caused by a de novo NR3C2 nonsense variant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: